Compare · ACB vs DFTX
ACB vs DFTX
Side-by-side comparison of Aurora Cannabis Inc. (ACB) and Definium Therapeutics Inc. (DFTX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ACB and DFTX operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- DFTX is the larger of the two at $2.57B, about 3.3x ACB ($775.1M).
- Over the past year, ACB is down 41.0% and DFTX is up 193.6% - DFTX leads by 234.6 points.
- Both names hit the wire about 3 times in the past 4 weeks.
- ACB has more recent analyst coverage (12 ratings vs 4 for DFTX).
- Company
- Aurora Cannabis Inc.
- Definium Therapeutics Inc.
- Price
- $3.43+1.33%
- $22.79-3.27%
- Market cap
- $775.1M
- $2.57B
- 1M return
- -0.29%
- -1.89%
- 1Y return
- -40.96%
- +193.63%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- News (4w)
- 3
- 3
- Recent ratings
- 12
- 4
Aurora Cannabis Inc.
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Latest ACB
- SEC Form 6-K filed by Aurora Cannabis Inc.
- Aurora Cannabis to Host Fourth Quarter and Fiscal Year 2026 Investor Conference Call and File Related Year End Information
- SEC Form 6-K filed by Aurora Cannabis Inc.
- Europe's Cannabis Boom Is Accelerating as Billions Flow into Licensed Markets
- SEC Form 6-K filed by Aurora Cannabis Inc.
- Aurora Granted Plant Breeders' Rights, Strengthening Leadership in Cannabis Science
- SEC Form 6-K filed by Aurora Cannabis Inc.
- Aurora Advances Global Medical Cannabis Portfolio with New Product Launches Across Key International Markets
- SEC Form 6-K filed by Aurora Cannabis Inc.
- SEC Form 6-K filed by Aurora Cannabis Inc.
Latest DFTX
- Definium Therapeutics Announces New Employee Inducement Grants
- Definium Therapeutics to Participate in the 2026 Jefferies Global Healthcare Conference
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
- Definium Therapeutics Announces First Patient Dosed in Ascend, the Second Phase 3 Pivotal Study of DT120 ODT in Major Depressive Disorder
- Definium Therapeutics Announces New Employee Inducement Grants
- SEC Form 10-Q filed by Definium Therapeutics Inc.
- Definium Therapeutics Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Definium Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights
- Definium Therapeutics to Report First Quarter 2026 Financial Results on May 7, 2026